Related content

What implications do the tolerability profiles of antiandrogens and other commonly used prostate cancer treatments have on patient care?

By Mason Malcolm  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 1, 2006-08 ,pp. : 27-35

Springer Publishing Company

Access to resources Recommend Favorite

Tolerability of hormone therapies for breast cancer: How informative are documented symptom profiles in medical notes for ‘well-tolerated’ treatments?

By Fellowes D.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 1, 2001-03 ,pp. : 73-81

Springer Publishing Company

Access to resources Recommend Favorite

Triptorelin in the Treatment of Prostate Cancer: Clinical Efficacy and Tolerability

By Heyns Chris F.  

American Journal of Cancer, Vol. 4, Iss. 3, 2005-01 ,pp. : 169-183

Adis International

Access to resources Recommend Favorite

You're Kidding...I Have Cancer? A Patient's Perspective on Coping With Prostate Cancer and Why Active Surveillance Was Not Chosen

By Lipton David A.  

Journal of the National Cancer Institute Monographs, Vol. 2012, Iss. 45, 2012-09 ,pp. : 140-142

Oxford University Press

Access to resources Recommend Favorite

Approaches Used in Immunotherapy for Prostate Cancer

By  

Current Cancer Therapy Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 238-244

Bentham Science Publishers

Access to resources Recommend Favorite